AIM Immunotech Inc.

The US Food and Drug Administration’s unusual public statement about an investigational drug to treat ALS may be aimed at tamping down the sponsor’s bullish comments to the patient community about its

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Deerfiel

Responding to the pleas of patients, the National Institutes of Health has awarded grants for collaborating research centers to ramp up research in myalgic encephalomyelitis, or chronic fatigue syndro

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c